Chemtura Reports 2008 Second Quarter Results
E I DuPont de Nemours and zu myNews hinzufügen Was ist das?
Chemtura Corporation (NYSE: CEM; the "Company”)
reports net loss of $278 million, or $1.15 per share, for the second
quarter of 2008 and net earnings on a managed basis of $45 million, or
$0.18 per share.
The discussion below includes information on both a GAAP and managed
basis. The Company presents managed basis financial information because
management uses this information internally to evaluate and direct the
performance of the Company’s operations and
believes that the managed basis financial information provides useful
information to investors. A reconciliation of GAAP and managed basis
financial information is provided in the supplemental schedules included
in this release.
The following is a summary of second
quarter results on a GAAP basis:
(In millions, except per share data)
Second Quarter
2008
2007
% change
Net sales
$
1,023
$
1,038
(1
)%
Operating (loss) profit
$
(248
)
$
1
NM
Loss from continuing operations
$
(278
)
$
(23
)
NM
Loss per share from continuing operations
$
(1.15
)
$
(0.09
)
NM
Earnings per share from discontinued operations
$
-
$
0.02
NM
Per share gain on sale of discontinued operations
$
-
$
0.10
NM
Net (loss) earnings per share
$
(1.15
)
$
0.03
NM
NM = Not Meaningful
The following is a summary of second
quarter results on a managed basis:
(In millions, except per share data)
Second Quarter
2008
2007
% change
Net sales
$
1,023
$
1,038
(1
)%
Operating profit
$
90
$
89
1
%
Earnings from continuing operations
$
45
$
37
22
%
Earnings per share from continuing operations
$
0.18
$
0.16
13
%
Earnings per share from discontinued operations
$
-
$
0.02
NM
Net earnings per share
$
0.18
$
0.18
-
NM = Not Meaningful
"The second quarter added another quarter of
solid progress despite the headwinds of raw material inflation and a
wet, cold start to the pool season in our Consumer business,”
said Robert L. Wood, Chemtura chairman and CEO.
"Our focus has been on three key areas:
portfolio structure, cost management and improved commercial excellence,”
Wood said. "We will continue to move forward
with the diverse portfolio of businesses we have built to achieve
growing earnings on a sustainable basis.
"Our Crop Protection business delivered
another very strong quarter with operating income up 60 percent on 18
percent growth in sales revenues. Performance Specialties also
contributed improved results despite higher raw material costs and a
sluggish manufacturing economy - operating income is up 15 percent on 13
percent growth in sales revenues. Consumer Products’
operating income slipped $6 million due to lower revenues as a result of
unseasonably cool conditions in the United States and European customers
still consuming inventory after the floods of 2007. Polymer Additives
felt the biggest impact of raw material inflation, which caused a $6
million decline in operating income versus the second quarter of 2007.
Nevertheless, sequential improvement was evident, with operating income
up $3 million from the first quarter 2008 making this quarter the
strongest in a year.
"We continued to benefit from our cost
reduction actions,” Wood said. "SGA&R
was $13 million or 11 percent lower than the second quarter of 2007 and
dropped to 11 percent of sales from 12 percent a year ago. Gross profit
margins were 24 percent, down from 25 percent a year ago, reflecting the
dramatic impact of raw material cost increases over the last year. These
raw material cost increases obscured the benefits we expected to see
from manufacturing rationalization and productivity improvements in many
of our plants.
"Finding ways to fully capture the value in
use for our products and drastically reduce the lag time between cost
increases and price increases, while understanding the challenges our
customers face, remains our biggest challenge. We are determined to be
successful in meeting this challenge. We have made progress, but we must
do more to adapt our commercial practices to today’s
less-stable conditions,” Wood added.
"After having announced the conclusion of the
first phase of the review of our strategic alternatives, we remain
focused on actions that will deliver greater immediate value to our
shareholders. Our objectives include a focus on reducing debt, reducing
the number of shares outstanding and improving EPS. We believe these
actions will deliver that value.
"Our goal for the second half of 2008 is to
continue to deliver year-over-year improvement despite economic
uncertainties that all businesses face,” Wood
said. "Our focus remains on delivering growth
while controlling costs to increase cash flow and profitability.” Second Quarter 2008 Business Segment Highlights
Polymer Additives revenues decreased by $37 million compared with the
second quarter of 2007. The divestiture of the oleochemicals and
organic peroxides businesses reduced revenues by $40 million.
Additionally, sales volume decreased by $26 million, primarily related
to reduced sales in plastic antioxidants. These reductions were
partially offset by higher selling prices of $15 million and favorable
foreign currency translation of $14 million. Operating profit on a
managed basis was 18% or $6 million lower than the second quarter of
2007, primarily due to the net impact of raw material and energy cost
increases which were partially offset by the benefit of higher selling
prices and improved product mix. On a GAAP basis, operating profit
declined 16% or $5 million, as compared with the second quarter of
2007.
Performance Specialties revenues grew by 13% or $29 million and
operating profit increased 15% or $4 million compared with the second
quarter of 2007. The revenue growth was primarily due to higher
selling prices of $13 million, increased sales volumes of $11 million
and favorable foreign currency translation of $5 million. Operating
profit benefited from higher selling prices and improved product mix.
However, these benefits were somewhat offset by increased raw
material, energy, manufacturing and freight costs.
Consumer Products revenues declined 3% or $7 million compared with the
second quarter of 2007. The decline in sales was due to a wet and cold
start to the 2008 pool season and lower European demand compared with
the second quarter of 2007. These impacts were partially offset by the
benefit of favorable foreign exchange translation. Operating profit
declined 16% or $6 million primarily due to lower revenues and
increased raw material and energy costs.
Crop Protection revenues, driven by increased sales from Europe and
Latin America, increased 18% or $17 million compared with the second
quarter of 2007. Operating income rose 60% or $9 million in the second
quarter as compared with the same quarter of 2007. This was largely
due to higher volume, reductions in selling, general and
administrative, and research and development expenses ("SGA&R”)
and favorable foreign currency translation. SGA&R in the second
quarter of 2007 included a provision for Latin American doubtful
accounts of $5 million.
Corporate expense for the quarter was $22 million, which included $11
million of amortization expense related to intangibles. This was
partially offset by a $3 million benefit related to the recovery of
insurance proceeds associated with hurricanes Katrina and Rita in
2005. Corporate expense in the second quarter of 2007 was $24 million,
which included $9 million of amortization expense related to
intangibles and $2 million related to the accelerated recognition of
asset retirement obligations.
Second Quarter 2008 Significant Transactions and Events
The Company continually monitors and evaluates business and
competitive conditions that affect the carrying value of the Company’s
goodwill by segment. In the second quarter, the Company updated its
strategic plans and long-term financial projections for each of its
businesses. The plans and projections related to the Consumer Products
business amply demonstrate the business’
ability to maintain its leading industry position in an attractive
market and its ability to continue to grow. Nevertheless, the plans
were not sufficient to sustain the high levels of goodwill associated
with this business and the Company has recorded a non-cash charge to
reduce the carrying value of goodwill by $320 million in accordance
with the requirements of SFAS No. 142, Goodwill and Other Intangible
Assets.
Second Quarter Results - GAAP
Revenue for the quarter was $1,023 million, or 1% below second quarter
2007 revenue of $1,038 million. The decrease in revenue was
attributable to $59 million from the impact of the divestitures of the
oleochemicals business, organic peroxides business and Celogen®
foaming agents product line and a $14 million impact from decreased
volume and product mix. The decrease was partially offset by $31
million from favorable foreign exchange translation and $27 million
from higher selling prices.
Gross profit decreased $7 million compared with the same period of
2007. The decrease in gross profit resulted from $43 million in higher
raw material and energy costs and $9 million from unfavorable
manufacturing variances and increased distribution costs, offset by
$27 million from higher selling prices, $7 million from favorable
foreign exchange translation, $6 million from improved product mix, $3
million from the recovery of insurance proceeds associated with
hurricanes Katrina and Rita in 2005 and other cost decreases of $2
million.
A non-cash charge of $320 million (subject to finalization) was
recorded in the second quarter of 2008 to reduce the carrying value of
goodwill in the Company’s Consumer Products
segment.
The operating loss for the second quarter of 2008 was $248 million
compared with a profit of $1 million for the second quarter of 2007.
The decrease in operating profit resulted from a $313 increase in
impairment of long-lived assets, primarily related to the impairment
of goodwill for Consumer in 2008 and a $7 million decrease in gross
profit discussed above. The decrease was partially offset by a $22
million decrease in facility closures, severance and related costs, a
$14 million decrease in loss on the sale of business, primarily
related to the Celogen®
business sold in 2007, a $13 million decrease in depreciation and
amortization primarily due to lower accelerated depreciation of
property, plant and equipment, a $13 million decrease in SGA&R, a $7
million decrease in antitrust costs and a $2 million increase in
equity income. The decrease in SGA&R included a reduction in provision
for doubtful accounts of $5 million for Crop Protection reflecting a
better economic environment in Latin America.
Other expense (net) decreased by $4 million in the second quarter of
2008 as compared with the same quarter last year. The decrease
primarily reflects a decrease in minority interest expense and lower
fees associated with the account receivable securitization program.
The loss from continuing operations for the second quarter of 2008 was
$278 million, or $1.15 per share, compared with a loss of $23 million,
or $0.09 per share, for the second quarter of 2007. The decrease
primarily reflects the $249 million decrease in operating profit
discussed above and a $14 million increase in income tax expense,
partially offset by a $4 million decrease in other expense, net and a
$4 million decrease in interest expense.
Earnings from discontinued operations for the second quarter of 2007
were $6 million (net of $3 million of tax) and reflect the
contribution from the EPDM, fluorine and optical monomers businesses
that were subsequently sold.
In the second quarter of 2007, the gain on the sale of discontinued
operations of $25 million (net of $13 million of tax) related to the
sale of the EPDM business.
Second Quarter Results - Managed Basis
On a managed basis, second quarter 2008 gross profit was $245 million,
or 24% of net sales, as compared with second quarter 2007 managed
basis gross profit of $259 million, or 25% of net sales. Increases in
raw material prices are the primary drivers in the reduction in margin
percentage.
On a managed basis, second quarter 2008 operating profit was $90
million as compared with second quarter 2007 managed basis operating
profit of $89 million, or 9% of net sales in both periods.
Earnings from continuing operations before income taxes on a managed
basis in 2008 and 2007 exclude pre-tax charges of $338 million and $88
million, respectively. These charges are primarily related to
accelerated depreciation of property, plant and equipment, facility
closures, severance and related costs, antitrust costs, loss on sale
of businesses, impairment of long-lived assets, accelerated
recognition of asset retirement obligations and insurance recovery
related to hurricane costs. The amounts associated with these charges
are detailed on page 14 of this release.
Chemtura’s managed basis tax rate of 35%
represents the expected effective tax rate for the Company’s
core operations. The Company has chosen to apply this rate to pre-tax
income on a managed basis to better reflect underlying operating
performance.
Earnings from discontinued operations on a managed basis principally
reflect the contribution of the EPDM, optical monomers and fluorine
businesses of $6 million for the quarter ended June 30, 2007.
Cash Flows - GAAP
Net cash provided by operations in the quarter ended June 30, 2008 was
$10 million as compared with $78 million in 2007. The change is
primarily due to increases in working capital, offset by higher
account receivable securitization levels.
The Company’s accounts receivable
securitization programs totaled $350 million as of June 30, 2008, $337
million as of March 31, 2008 and $306 million as of June 30, 2007.
At June 30, 2008, the Company’s inventory
balance was $727 million as compared with $707 million at March 31,
2008. The increase was primarily due to seasonal demands and increased
raw material costs.
Capital expenditures for the quarter ended June 30, 2008 were $36
million compared with $26 million in 2007. The Company continues to
anticipate capital expenditures of $165 million for the calendar year
2008, which includes $25 million related to the consolidation of its
legacy ERP systems onto a single instance of SAP.
The Company’s total debt as of June 30,
2008 was $1,115 million as compared with $1,092 million as of March
31, 2008. Cash and cash equivalents were $110 million as of June 30,
2008 compared to $115 million as of March 31, 2008.
Second Quarter Earnings Q&A Teleconference
Copies of this release as well as informational slides will be available
on the Investor Relations section of the Company’s
Web site at www.chemtura.com. The
Company will host a teleconference to review these results on Friday,
August 1, at 9:00 a.m. EDT. Interested parties are asked to dial in
approximately 10 minutes prior to the start time at (913) 312-0704.
Replay of the call will be available for two weeks starting at noon EDT
on Friday, August 1, 2008. To access the replay, call (719) 457-0820 and
enter access code 7241068.
Live Internet access to the 2008 second quarter conference call will be
available through the Investor Relations section of the Company’s
Web site. If you need further information pertaining to the call, please
contact Shirley Cronan at (203) 573-2213.
Chemtura Corporation, with 2007 sales of $3.7 billion, is a global
manufacturer and marketer of specialty chemicals, crop protection and
pool, spa and home care products. Additional information concerning
Chemtura is available at www.chemtura.com.
Managed Basis Financial Measures The information presented in this press release and in the attached
financial tables includes financial measures that are not calculated or
presented in accordance with Generally Accepted Accounting Principles in
the United States (GAAP). These managed basis financial measures
consist of adjusted results of operations of the Company that exclude
certain expenses, gains and losses that may not be indicative of the
core operations of the Company. Excluded items include facility
closures, severance and related costs, antitrust costs, merger costs,
increased depreciation due to the change in useful life of assets,
unusual and non-recurring settlements, accelerated recognition of asset
retirement obligations and impairment of long-lived assets. In addition
to the managed basis financial measures discussed above, the Company has
applied a managed basis effective income tax rate to our managed basis
income before taxes. Chemtura’s managed basis
tax rate of 35% beginning with the third quarter of 2007 represents the
expected effective tax rate for the Company’s
core operations. Reconciliations of these managed basis financial
measures to their most directly comparable GAAP financial measures are
provided in the attached financial tables. The Company believes
that such managed basis financial measures provide useful information to
investors and may assist them in evaluating the Company’s
underlying performance and identifying operating trends. In
addition, management uses these managed basis financial measures
internally to allocate resources and evaluate the performance of the
Company’s operations. While the
Company believes that such measures are useful in evaluating the Company’s
performance, investors should not consider them to be a substitute for
financial measures prepared in accordance with GAAP. In addition,
these managed basis financial measures may differ from similarly titled
managed basis financial measures used by other companies and do not
provide a comparable view of the Company's performance relative to other
companies in similar industries. Forward-Looking Statement This document includes forward-looking statements. These
forward-looking statements are identified by terms and phrases such as "anticipate,” "believe,” "intend,” "estimate,” "expect,” "continue,” "should,” "could,” "may,” "plan,” "project,” "predict,” "will”
and similar expressions and include references to assumptions and relate
to our future prospects, developments and business strategies. Factors that could cause our actual results to differ materially from
those expressed or implied in such forward-looking statements include,
but are not limited to: General economic conditions; Significant international operations and interests; The ability to obtain increases in selling prices to offset
increases in raw material and energy costs; The ability to retain sales volumes in the event of increasing
selling prices; The ability to absorb fixed cost overhead in the event of lower
volumes; Pension and other post-retirement benefit plan assumptions; The ability to successfully complete the restructuring and
turnaround of our Polymer Additives segment; The ability to obtain growth from demand for petroleum additive,
lubricant and agricultural product applications; The ability to sustain profitability in our Crop Protection
business due to new generic competition and the failure to secure new
products and technology. Additionally, the Crop Protection business is
dependent on disease and pest conditions, as well as local, regional,
regulatory and economic conditions; The ability to sell methyl bromide due to regulatory restrictions; Changes in weather conditions which could adversely affect the
seasonal selling cycles in both our Consumer Products and Crop
Protection segments; Changes in the availability and/or quality of our energy and raw
materials; The ability to collect our outstanding receivables; Changes in interest rates and foreign currency exchange rates; Changes in technology, market demand and customer requirements; The enactment of more stringent domestic and international
environmental laws and regulations; The ability to realize expected cost savings under our
restructuring plans, Six Sigma and Lean manufacturing initiatives; The outcome of our review of strategic alternatives; The ability to reduce our indebtedness levels; The ability to recover our deferred tax assets; The ability to successfully complete the Company’s
new SAP platform initiative; The ability to support the goodwill in our business segments; The ability to remain compliant with our debt covenants or obtain
necessary waivers; and Other risks and uncertainties detailed in Item 1A. Risk Factors or
in our filings with the Securities and Exchange Commission. These statements are based on the Company’s
estimates and assumptions and on currently available information. The
forward-looking statements include information concerning the Company’s
possible or assumed future results of operations, and the Company’s
actual results may differ significantly from the results discussed. Forward-looking
information is intended to reflect opinions as of the date this press
release was issued and such information will not necessarily be updated
by the Company. CHEMTURA CORPORATION
Index of Financial Statements and Schedules
Page
Financial Statements
Consolidated Statements of Operations (Unaudited) - Quarter and
Six Months ended June 30, 2008 and 2007
9
Consolidated Balance Sheets - June 30, 2008 (Unaudited) and
December 31, 2007
10
Condensed Consolidated Statements of Cash Flows (Unaudited) - Six
Months ended June 30, 2008 and 2007
11
Segment Net Sales and Operating Profit (Loss) (Unaudited) -
Quarter and Six Months ended June 30, 2008 and 2007
12
Supplemental Schedules
Major Factors Affecting Net Sales and Operating Results
(Unaudited) - Quarter and Six Months ended June 30, 2008 versus
2007
13
Managed Basis Consolidated Statements of Operations (Unaudited) -
Quarter ended June 30, 2008 and 2007
14
Managed Basis Consolidated Statements of Operations (Unaudited) -
Six Months ended June 30, 2008 and 2007
15
Managed Basis Segment Net Sales and Operating Profit (Loss)
(Unaudited) - Quarter ended June 30, 2008 and 2007
16
Managed Basis Segment Net Sales and Operating Profit (Loss)
(Unaudited) - Six Months ended June 30, 2008 and 2007
17
CHEMTURA CORPORATION Consolidated Statements of Operations (Unaudited)
(In millions, except per share data)
Quarter Ended June 30, Six Months Ended June 30, 2008 2007 2008 2007
Net sales
$
1,023
$
1,038
$
1,932
$
1,927
Cost of goods sold
775
783
1,500
1,470
Selling, general and administrative
95
107
180
205
Depreciation and amortization
57
70
126
133
Research and development
14
15
28
31
Facility closures, severance and related costs
-
22
-
25
Antitrust costs
11
18
11
30
Loss on sale of business
1
15
24
15
Impairment of long-lived assets
320
7
320
7
Equity income
(2
)
-
(3
)
(1
)
Operating (loss) profit
(248
)
1
(254
)
12
Interest expense
(19
)
(23
)
(39
)
(46
)
Other (expense) income, net
(2
)
(6
)
12
(4
)
Loss from continuing operations before income taxes
(269
)
(28
)
(281
)
(38
)
Income tax (expense) benefit
(9
)
5
(18
)
(5
)
Loss from continuing operations
(278
)
(23
)
(299
)
(43
)
Earnings from discontinued operations
-
6
-
11
Gain on sale of discontinued operations
-
25
-
27
Net (loss) earnings
$
(278
)
$
8
$
(299
)
$
(5
)
Basic and diluted earnings (loss) per common share:
Loss from continuing operations
$
(1.15
)
$
(0.09
)
$
(1.24
)
$
(0.18
)
Earnings from discontinued operations
-
0.02
-
0.05
Gain on sale of discontinued operations
-
0.10
-
0.11
Net (loss) earnings
$
(1.15
)
$
0.03
$
(1.24
)
$
(0.02
)
Weighted average shares outstanding - basic and diluted
242.2
241.4
242.2
241.2
CHEMTURA CORPORATION Consolidated Balance Sheets
(In millions)
June 30, 2008 December 31, 2007 ASSETS (Unaudited)
CURRENT ASSETS
Cash and cash equivalents
$
110
$
77
Accounts receivable
400
389
Inventories
727
676
Other current assets
255
239
Total current assets
1,492
1,381
NON-CURRENT ASSETS
Property, plant and equipment, net
971
1,032
Goodwill
996
1,309
Intangible assets, net
565
585
Other assets
127
109
$
4,151
$
4,416
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Short-term borrowings
$
41
$
5
Accounts payable
304
285
Accrued expenses
318
353
Income taxes payable
45
38
Total current liabilities
708
681
NON-CURRENT LIABILITIES
Long-term debt
1,074
1,058
Pension and post-retirement health care liabilities
350
361
Other liabilities
392
463
STOCKHOLDERS' EQUITY
Common stock
3
3
Additional paid-in capital
3,035
3,028
Accumulated deficit
(1,504
)
(1,179
)
Accumulated other comprehensive income
260
168
Treasury stock at cost
(167
)
(167
)
Total stockholders' equity
1,627
1,853
$
4,151
$
4,416
CHEMTURA CORPORATION Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Six Months Ended June 30, Increase (decrease) to cash 2008 2007 CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
$
(299
)
$
(5
)
Adjustments to reconcile net loss to net cash provided by
operations:
Loss on sale of business
24
15
Gain on sale of discontinued operations
-
(27
)
Impairment of long-lived assets
320
7
Depreciation and amortization
126
138
Stock-based compensation expense
5
5
Equity income, net of cash distributions
(3
)
(1
)
Changes in assets and liabilities, net
(147
)
(85
)
Net cash provided by operations
26
47
CASH FLOWS FROM INVESTING ACTIVITIES
Net proceeds from divestments
68
132
Payments for acquisitions, net of cash acquired
(26
)
(164
)
Capital expenditures
(59
)
(46
)
Net cash used in investing activities
(17
)
(78
)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from credit facility, net
50
-
Proceeds from long term borrowings
1
-
Payments on long term borrowings
(31
)
-
Proceeds from short term borrowings
25
31
Dividends paid
(24
)
(24
)
Proceeds from exercise of stock options
1
4
Other financing activities
(1
)
-
Net cash provided by financing activities
21
11
CASH
Effect of exchange rates on cash and cash equivalents
3
1
Change in cash and cash equivalents
33
(19
)
Cash and cash equivalents at beginning of period
77
95
Cash and cash equivalents at end of period
$
110
$
76
CHEMTURA CORPORATION Segment Net Sales and Operating Profit (Loss) (Unaudited)
(In millions)
Quarter Ended June 30, Six Months Ended June 30, 2008 2007 2008 2007 NET SALES
Polymer Additives
$
438
$
475
$
880
$
919
Performance Specialties
261
232
516
443
Consumer Products
194
201
301
317
Crop Protection
114
97
203
178
Other
16
33
32
70
Total Net Sales
$
1,023
$
1,038
$
1,932
$
1,927
OPERATING PROFIT (LOSS)
Polymer Additives
$
27
$
32
$
35
$
57
Performance Specialties
31
27
57
54
Consumer Products
32
38
33
36
Crop Protection
24
15
45
29
Other
1
(3
)
1
(4
)
115
109
171
172
General corporate expense, including amortization
(22
)
(24
)
(54
)
(47
)
Accelerated depreciation of property, plant and equipment
(9
)
(22
)
(16
)
(36
)
Facility closures, severance and related costs
-
(22
)
-
(25
)
Antitrust costs
(11
)
(18
)
(11
)
(30
)
Loss on sale of business
(1
)
(15
)
(24
)
(15
)
Impairment of long-lived assets
(320
)
(7
)
(320
)
(7
)
Total Operating (Loss) Profit
$
(248
)
$
1
$
(254
)
$
12
CHEMTURA CORPORATION Major Factors Affecting Net Sales and Operating Results
(Unaudited) Quarter and Six Months Ended June 30, 2008 versus 2007
(In millions)
The following table summarizes the major factors contributing to
the changes in operating results versus the prior year:
Quarter Ended June 30,
Six Months Ended June 30, Net Sales
Pre-tax Earnings (Loss) from Continuing Operations Net Sales
Pre-tax Earnings (Loss) from Continuing Operations
2007
$
1,038
$
(28
)
$
1,927
$
(38
)
2007 Accelerated recognition of asset retirement obligation
-
4
-
7
2007 Accelerated depreciation of property, plant and equipment
-
22
-
36
2007 Facility closures, severance and related costs
-
22
-
25
2007 Antitrust costs
-
18
-
30
2007 Loss on sale of business
-
15
-
15
2007 Impairment of long-lived assets
-
7
-
7
1,038
60
1,927
82
Higher selling prices
27
27
46
46
Unit volume and mix
(14
)
6
(21
)
5
Foreign currency impact
31
5
55
2
Acquisitions
-
-
20
4
Divestitures
(59
)
(1
)
(95
)
-
Manufacturing variances
-
(9
)
-
(9
)
Higher raw materials/energy costs
-
(43
)
-
(73
)
Reductions in SGA&R, excluding foreign exchange impact
-
15
-
33
Lower A/R securitization fees
-
1
-
3
Foreign exchange gain (loss)
-
(1
)
-
12
Lease accounting
-
-
-
(7
)
Lower interest expense
-
4
-
7
Other
-
5
-
(1
)
1,023
69
1,932
104
2008 Accelerated recognition of asset retirement obligation
-
-
-
(2
)
2008 Insurance recovery - hurricane costs
-
3
-
3
2008 Accelerated depreciation of property, plant and equipment
-
(9
)
-
(31
)
2008 Antitrust costs
-
(11
)
-
(11
)
2008 Loss on sale of business
-
(1
)
-
(24
)
2008 Impairment of long-lived assets
-
(320
)
-
(320
)
2008
$
1,023
$
(269
)
$
1,932
$
(281
)
CHEMTURA CORPORATION Managed Basis Consolidated Statements of Operations (Unaudited)
(In millions, except per share data)
Quarter Ended June 30, 2008 Quarter Ended June 30, 2007
GAAP Managed Basis Adjustment Managed Basis GAAP Managed Basis Adjustment Managed Basis
Net sales
$
1,023
$
-
$
1,023
$
1,038
$
-
$
1,038
Cost of goods sold
775
3
778
783
(4
)
779
Selling, general and administrative
95
-
95
107
-
107
Depreciation and amortization
57
(9
)
48
70
(22
)
48
Research and development
14
-
14
15
-
15
Facility closures, severance and related costs
-
-
-
22
(22
)
-
Antitrust costs
11
(11
)
-
18
(18
)
-
Loss on sale of business
1
(1
)
-
15
(15
)
-
Impairment of long-lived assets
320
(320
)
-
7
(7
)
-
Equity income
(2
)
-
(2
)
-
-
-
Operating (loss) profit
(248
)
338
90
1
88
89
Interest expense
(19
)
-
(19
)
(23
)
-
(23
)
Other expense, net
(2
)
-
(2
)
(6
)
-
(6
)
(Loss) earnings from continuing operations before income taxes
(269
)
338
69
(28
)
88
60
Income tax (expense) benefit
(9
)
(15
)
(24
)
5
(28
)
(23
)
(Loss) earnings from continuing operations
(278
)
323
45
(23
)
60
37
Earnings from discontinued operations
-
-
-
6
-
6
Gain on sale of discontinued operations
-
-
-
25
(25
)
-
Net (loss) earnings
$
(278
)
$
323
$
45
$
8
$
35
$
43
Diluted earnings from continuing operations
$
0.18
$
0.16
Diluted earnings from discontinued operations
-
0.02
Diluted net earnings
$
0.18
$
0.18
Diluted weighted average shares outstanding
242.2
242.2
Managed Basis Adjustments consist of the following: Quarter Ended June 30, 2008 Quarter Ended June 30, 2007
Accelerated recognition of asset retirement obligation
$
-
$
4
Insurance recovery - hurricane costs
(3
)
-
Accelerated depreciation of property, plant and equipment
9
22
Facility closures, severance and related costs
-
22
Antitrust costs
11
18
Loss on sale of business
1
15
Impairment of long-lived assets
320
7
Pre-Tax
338
88
Adjustment to apply a managed basis effective tax rate
(15
)
(28
)
After-Tax
323
60
Gain on sale of discontinued operations
-
(25
)
Net earnings (loss)
$
323
$
35
CHEMTURA CORPORATION Managed Basis Consolidated Statements of Operations (Unaudited)
(In millions, except per share data)
Six Months Ended June 30, 2008 Six Months Ended June 30, 2007 GAAP Managed Basis Adjustment Managed Basis GAAP Managed Basis Adjustment Managed Basis
Net sales
$
1,932
$
-
$
1,932
$
1,927
$
-
$
1,927
Cost of goods sold
1,500
1
1,501
1,470
(7
)
1,463
Selling, general and administrative
180
-
180
205
-
205
Depreciation and amortization
126
(31
)
95
133
(36
)
97
Research and development
28
-
28
31
-
31
Facility closures, severance and related costs
-
-
-
25
(25
)
-
Antitrust costs
11
(11
)
-
30
(30
)
-
Loss on sale of business
24
(24
)
-
15
(15
)
-
Impairment of long-lived assets
320
(320
)
-
7
(7
)
-
Equity income
(3
)
-
(3
)
(1
)
-
(1
)
Operating (loss) profit
(254
)
385
131
12
120
132
Interest expense
(39
)
-
(39
)
(46
)
-
(46
)
Other income (expense), net
12
-
12
(4
)
-
(4
)
(Loss) earnings from continuing operations before income taxes
(281
)
385
104
(38
)
120
82
Income tax expense
(18
)
(18
)
(36
)
(5
)
(25
)
(30
)
(Loss) earnings from continuing operations
(299
)
367
68
(43
)
95
52
Earnings from discontinued operations
-
-
-
11
-
11
Gain on sale of discontinued operations
-
-
-
27
(27
)
-
Net (loss) earnings
$
(299
)
$
367
$
68
$
(5
)
$
68
$
63
Diluted earnings from continuing operations
$
0.28
$
0.21
Diluted earnings from discontinued operations
-
0.05
Diluted net earnings
$
0.28
$
0.26
Diluted weighted average shares outstanding
242.2
242.2
Managed Basis Adjustments consist of the following: Six Months Ended June 30, 2008 Six Months Ended June 30, 2007
Accelerated recognition of asset retirement obligation
$
2
$
7
Insurance recovery - hurricane costs
(3
)
-
Accelerated depreciation of property, plant and equipment
31
36
Facility closures, severance and related costs
-
25
Antitrust costs
11
30
Loss on sale of business
24
15
Impairment of long-lived assets
320
7
Pre-Tax
385
120
Adjustment to apply a managed basis effective tax rate
(18
)
(25
)
After-Tax
367
95
Gain on sale of discontinued operations
-
(27
)
Net earnings
$
367
$
68
CHEMTURA CORPORATION Managed Basis Segment Net Sales and Operating Profit (Loss)
(Unaudited)
(In millions)
Quarter Ended June 30, 2008 Quarter Ended June 30, 2007 GAAP Managed Basis Adjustments Managed Basis GAAP Managed Basis Adjustments Managed Basis NET SALES
Polymer Additives
$
438
$
-
$
438
$
475
$
-
$
475
Performance Specialties
261
-
261
232
-
232
Consumer Products
194
-
194
201
-
201
Crop Protection
114
-
114
97
-
97
Other
16
-
16
33
-
33
Total Net Sales
$
1,023
$
-
$
1,023
$
1,038
$
-
$
1,038
OPERATING PROFIT (LOSS)
Polymer Additives
$
27
$
-
$
27
$
32
$
1
$
33
Performance Specialties
31
-
31
27
-
27
Consumer Products
32
-
32
38
-
38
Crop Protection
24
-
24
15
-
15
Other
1
-
1
(3
)
1
(2
)
115
-
115
109
2
111
General corporate expense, including amortization
(22
)
(3
)
(25
)
(24
)
2
(22
)
Change in useful life of property, plant and equipment
(9
)
9
-
(22
)
22
-
Facility closures, severance and related costs
-
-
-
(22
)
22
-
Antitrust costs
(11
)
11
-
(18
)
18
-
Loss on sale of business
(1
)
1
-
(15
)
15
-
Impairment of long-lived assets
(320
)
320
-
(7
)
7
-
Total Operating (Loss) Profit
$
(248
)
$
338
$
90
$
1
$
88
$
89
DEPRECIATION AND AMORTIZATION
Polymer Additives
$
22
$
-
$
22
$
22
$
-
$
22
Performance Specialties
7
-
7
6
-
6
Consumer Products
3
-
3
1
-
1
Crop Protection
2
-
2
1
-
1
Other
-
-
-
1
-
1
General corporate expense, including amortization
23
(9
)
14
39
(22
)
17
Total Depreciation and Amortization
$
57
$
(9
)
$
48
$
70
$
(22
)
$
48
Managed Basis Adjustments consist of the following: Quarter Ended June 30, 2008 Quarter Ended June 30, 2007
Accelerated recognition of asset retirement obligation
$
-
$
4
Insurance recovery - hurricane costs
(3
)
-
Accelerated depreciation of property, plant and equipment
9
22
Facility closures, severance and related costs
-
22
Antitrust costs
11
18
Loss on sale of business
1
15
Impairment of long-lived assets
320
7
$
338
$
88
CHEMTURA CORPORATION Managed Basis Segment Net Sales and Operating Profit (Loss)
(Unaudited)
(In millions)
Six Months Ended June 30, 2008 Six Months Ended June 30, 2007 GAAP Managed Basis Adjustments Managed Basis GAAP Managed Basis Adjustments Managed Basis NET SALES
Polymer Additives
$
880
$
-
$
880
$
919
$
-
$
919
Performance Specialties
516
-
516
443
-
443
Consumer Products
301
-
301
317
-
317
Crop Protection
203
-
203
178
-
178
Other
32
-
32
70
-
70
Total Net Sales
$
1,932
$
-
$
1,932
$
1,927
$
-
$
1,927
OPERATING PROFIT (LOSS)
Polymer Additives
$
35
$
16
$
51
$
57
$
1
$
58
Performance Specialties
57
1
58
54
-
54
Consumer Products
33
-
33
36
-
36
Crop Protection
45
-
45
29
-
29
Other
1
-
1
(4
)
4
-
171
17
188
172
5
177
General corporate expense, including amortization
(54
)
(3
)
(57
)
(47
)
2
(45
)
Change in useful life of property, plant and equipment
(16
)
16
-
(36
)
36
-
Facility closures, severance and related costs
-
-
-
(25
)
25
-
Antitrust costs
(11
)
11
-
(30
)
30
-
Loss on sale of business
(24
)
24
-
(15
)
15
-
Impairment of long-lived assets
(320
)
320
-
(7
)
7
-
Total Operating (Loss) Profit
$
(254
)
$
385
$
131
$
12
$
120
$
132
DEPRECIATION AND AMORTIZATION
Polymer Additives
$
60
$
(14
)
$
46
$
43
$
-
$
43
Performance Specialties
14
(1
)
13
11
-
11
Consumer Products
6
-
6
7
-
7
Crop Protection
4
-
4
2
-
2
Other
-
-
-
2
-
2
General corporate expense, including amortization
42
(16
)
26
68
(36
)
32
Total Depreciation and Amortization
$
126
$
(31
)
$
95
$
133
$
(36
)
$
97
Managed Basis Adjustments consist of the following: Six Months Ended June 30, 2008 Six Months Ended June 30, 2007
Accelerated recognition of asset retirement obligation
$
2
$
7
Insurance recovery - hurricane costs
(3
)
-
Accelerated depreciation of property, plant and equipment
31
36
Facility closures, severance and related costs
-
25
Antitrust costs
11
30
Loss on sale of business
24
15
Impairment of long-lived assets
320
7
$
385
$
120